1. 3D Printing of Poloxamer 407 Nanogel Discs and Their Applications in Adjuvant Ovarian Cancer Therapy
- Author
-
Rui Tang, Udayabhanu Jammalamadaka, Julie L. Prior, Samuel Achilefu, Hyunah Cho, Karthik Tappa, and Christopher Egbulefu
- Subjects
Paclitaxel ,medicine.medical_treatment ,Pharmaceutical Science ,Poloxamer ,02 engineering and technology ,030226 pharmacology & pharmacy ,Article ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,In vivo ,Drug Discovery ,medicine ,Animals ,Humans ,Ovarian Neoplasms ,Sirolimus ,Antibiotics, Antineoplastic ,021001 nanoscience & nanotechnology ,medicine.disease ,Biocompatible material ,Xenograft Model Antitumor Assays ,chemistry ,Printing, Three-Dimensional ,Poloxamer 407 ,Cancer research ,Molecular Medicine ,Female ,0210 nano-technology ,Ovarian cancer ,Adjuvant ,medicine.drug ,Nanogel - Abstract
Nanogels are attractive biocompatible materials that enable local delivery of multiple drugs. In this study, we demonstrated that 3D printing technology could be used to precisely construct nanogel discs carrying paclitaxel and rapamycin. 3D-printed nanogel disc rounds (12 mm diameter × 1 mm thickness) carrying paclitaxel and rapamycin evaded premature gelation during storage and the initial burst release of the drugs in the dissolution medium. In vivo 3D-printed nanogel discs permitted successful intraperitoneal delivery of paclitaxel and rapamycin in ES-2-luc ovarian-cancer-bearing xenograft mice. They were also shown to be therapeutically effective and capable of preventing postsurgical peritoneal adhesions in the treated xenograft mice.
- Published
- 2019
- Full Text
- View/download PDF